Researchers identify gene largely accounting for 15q13.3 microdeletion syndrome

February 2, 2018, Baylor College of Medicine
Credit: CC0 Public Domain

Researchers are closer to solving the puzzle of a complex neurological condition called 15q13.3 microdeletion syndrome. Individuals with this condition are missing a small piece of chromosome 15 that usually contains six genes, but which one of the genes is responsible for the clinical characteristics of patients has not been clear. In this study, a multidisciplinary team of researchers at Baylor College of Medicine and Texas Children's Hospital has identified in a mouse model OTUD7A as the gene within the deleted region that accounts for many characteristics of the human condition. The researchers also discovered that mice deficient in the gene Otud7a have fewer dendritic spines, small protrusions involved in neuron communication, which might be related to the neurological deficits. The report appears in the American Journal of Human Genetics.

"Identifying the gene within a deleted region of a chromosome that accounts for the clinical characteristics we see in is very important," said senior author Dr. Christian Schaaf, assistant professor of molecular and human genetics at Baylor College of Medicine and the Joan and Stanford Alexander Endowed Chair for Neuropsychiatric Genetics at Texas Children's Hospital. "If we want to get to the point where we can treat patients, we need to know which gene or genes to target. That is the big picture question behind this study."

The 15q13.3 microdeletion syndrome is characterized by a wide spectrum of neurodevelopmental disorders, including developmental delay, intellectual disability, epilepsy, language impairment, abnormal behaviors, neuropsychiatric disorders and hypotonia. Schaaf and his colleagues have studied the 15q13.3 microdeletion syndrome for several years trying to answer the question of which gene within that region may account for the patients' characteristics. "We have addressed that question from different standpoints using different kinds of technology," Schaaf said. "One way is with mouse models. We genetically engineer mice to lack a certain gene, and determine whether the animals show any features similar to what we see in the patients. For example, if the patients have epilepsy, we knockout a gene we suspect is involved in epilepsy and determine whether the mice also have the condition."

Of the six genes usually present within the deleted region in 15q13.3 microdeletion syndrome, the gene OTUD7A was considered a strong candidate, as it is one of only two that are always involved in the deletion, based on hundreds of patients studied by Schaaf and his colleagues. To test the relevance of the suspect gene, the researchers genetically engineered mice to lack this gene and observed that the mice indeed had many of the characteristics present in patients. In addition, they discovered that the gene is expressed in and that mice without the gene have fewer dendritic spines than those with it.

"We now have two new pieces of this complex genetic puzzle," Schaaf said. "We found that the gene Otud7a seems to play a major role in many of the neurological problems observed in our mouse model, and that this gene could be considered a therapeutic target for the human condition."

"We also learned that this gene is involved in the regulation of dendritic spine density. Altogether, our findings suggest that a deficiency in the gene OTUD7A is a major contributor to the clinical characteristics associated with the 15q13.3 microdeletion syndrome via changes in the number of dendritic spines and their activity," he said.

Schaaf and his colleagues think that the Otud7a knockout mouse line they have engineered would be a valuable resource to other researchers who wish to study this condition further. They have deposited the mouse line with the Jackson Laboratory for immediate availability.

Explore further: How having too much or too little of CHRNA7 can lead to neuropsychiatric disorders

More information: Jiani Yin et al, Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome, The American Journal of Human Genetics (2018). DOI: 10.1016/j.ajhg.2018.01.005

Related Stories

How having too much or too little of CHRNA7 can lead to neuropsychiatric disorders

November 28, 2017
Studying the genetic code allows researchers to know whether some patients with neuropsychiatric disorders either have extra copies of the CHRNA7 gene or are missing copies. However, little was known about the functional ...

Gene ABL1 implicated in both cancer and a developmental disorder

March 14, 2017
ABL1, a human gene well-known for its association with cancer now has been linked to a developmental disorder. The study, which was carried out by a team of researchers from institutions around the world, including Baylor ...

CRKL in 22q11.2; a key gene that contributes to common birth defects

May 25, 2017
The 22q11.2 region of human chromosome 22 is a hotspot for a variety of birth defects. Scientists learned about this region because it is deleted in about 1 in 4,000 births, causing the loss or duplication of up to 40 genes. ...

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Genetic cause identified for previously unrecognized developmental disorder

December 22, 2016
An international team of scientists has identified variants of the gene EBF3 causing a developmental disorder with features in common with autism. Identification of these gene variants leads to a better understanding of these ...

Unexplained developmental disorder linked to gene involved in essential cellular processes

August 18, 2016
A neurodevelopmental disorder for which there was no known cause has been linked to SON, a gene that is involved in essential mechanisms a cell uses to translate DNA into protein, as well as in DNA replication and cell division. ...

Recommended for you

Identifying Crohn's disease risk factors in the Ashkenazi Jewish population

May 25, 2018
It is estimated that one in three individuals of Ashkenazi Jewish (AJ) descent carry mutations that increase their risk for certain genetic diseases. For instance, Crohn's, a highly heritable inflammatory bowel disease, is ...

How do insects survive on a sugary diet?

May 25, 2018
There's a reason parents tell their kids to lay off the sugar: too much isn't good for you.

Regulatory mutations missed in standard genetic screening lead to congenital diseases

May 25, 2018
Researchers have identified a type of genetic aberration to be the cause of certain neurodevelopmental disorders and congenital diseases, such as autism and congenital heart disease, which are undetectable by conventional ...

New chromosome study can lead to personalised counselling of pregnant women

May 25, 2018
Foetuses with a so-called new balanced chromosomal aberration have a higher risk of developing brain disorders such as autism and mental retardation than previously anticipated. The risk is 20 per cent for foetuses with these ...

New findings on autism-related disorder

May 24, 2018
In a study published today in Nature, Marc Bühler and his group at the Friedrich Miescher Institute for Biomedical Research (FMI) have taken a major step forward in elucidating the mechanisms underlying a disorder known ...

Genome study presents new way to track historical demographics of US populations

May 24, 2018
Sharon Browning of the University of Washington and colleagues developed a method to estimate historical effective population size, which is the number of individuals who pass on their genes to the next generation, to reveal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.